FI893520A - Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi - Google Patents
Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi Download PDFInfo
- Publication number
- FI893520A FI893520A FI893520A FI893520A FI893520A FI 893520 A FI893520 A FI 893520A FI 893520 A FI893520 A FI 893520A FI 893520 A FI893520 A FI 893520A FI 893520 A FI893520 A FI 893520A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- pharmaceutical composition
- intravenous pharmaceutical
- intravenous
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU379688 | 1988-07-21 | ||
HU883796A HU201567B (en) | 1988-07-21 | 1988-07-21 | Process for production of intravenous medical compositions containing cyclosphorin |
Publications (4)
Publication Number | Publication Date |
---|---|
FI893520A0 FI893520A0 (fi) | 1989-07-21 |
FI893520A true FI893520A (fi) | 1990-01-22 |
FI92556B FI92556B (fi) | 1994-08-31 |
FI92556C FI92556C (fi) | 1994-12-12 |
Family
ID=10965544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI893520A FI92556C (fi) | 1988-07-21 | 1989-07-21 | Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi |
Country Status (26)
Country | Link |
---|---|
US (1) | US5047396A (fi) |
JP (1) | JPH07116051B2 (fi) |
KR (1) | KR0137674B1 (fi) |
AR (1) | AR243382A1 (fi) |
AT (1) | AT402258B (fi) |
AU (1) | AU614862B2 (fi) |
BE (1) | BE1004323A4 (fi) |
CA (1) | CA1332712C (fi) |
CH (1) | CH679120A5 (fi) |
DD (1) | DD283934A5 (fi) |
DE (1) | DE3924207A1 (fi) |
DK (1) | DK175540B1 (fi) |
FI (1) | FI92556C (fi) |
FR (1) | FR2635265B1 (fi) |
GB (1) | GB2221157B (fi) |
GR (1) | GR1002184B (fi) |
HU (1) | HU201567B (fi) |
IL (1) | IL91069A (fi) |
IT (1) | IT1231434B (fi) |
LU (1) | LU87560A1 (fi) |
NL (1) | NL194578C (fi) |
NO (1) | NO175287C (fi) |
NZ (1) | NZ230036A (fi) |
PT (1) | PT91246B (fi) |
SE (1) | SE509174C2 (fi) |
ZA (1) | ZA895588B (fi) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
GB2251186A (en) * | 1990-12-04 | 1992-07-01 | Randall Neal Gatz | Polypeptide for use in treatment of autoimmune disease |
GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
DE69307505T2 (de) | 1992-05-13 | 1997-07-24 | Sandoz-Patent-Gmbh, 79539 Loerrach | Opthalmische zusammensetzungen enthaltend ein cyclosporin |
ES2168271T3 (es) | 1992-09-25 | 2002-06-16 | Novartis Ag | Composiciones farmaceuticas que contienen ciclosporinas. |
DE4412201A1 (de) * | 1993-04-20 | 1994-11-10 | Rentschler Arzneimittel | Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin |
CH686761A5 (de) | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
US20020099067A1 (en) * | 1993-07-08 | 2002-07-25 | Ulrich Posanski | Pharmaceutical compositions for sparingly soluble therapeutic agents |
TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
DE4340781C3 (de) * | 1993-11-30 | 2000-01-27 | Novartis Ag | Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung |
KR0146671B1 (ko) * | 1994-02-25 | 1998-08-17 | 김충환 | 사이클로스포린-함유 분말 조성물 |
HUT77283A (hu) * | 1994-11-03 | 1998-03-30 | Novartis Ag. | Egyszerű összetételű, a hatóanyagot biológiailag jól hozzáférhetően tartalmazó, orális alkalmazásra szánt új ciklosporinkészítmény és eljárás az előállítására |
US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
PL319898A1 (en) * | 1995-08-25 | 1997-09-01 | Sangstat Medical Corp | Cyclosporines containing compositions for oral administration |
US20050053594A1 (en) * | 1995-11-16 | 2005-03-10 | Dario Alessi | RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
DE19544507B4 (de) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
US5858401A (en) * | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
GB2335854B (en) * | 1997-01-30 | 2001-04-25 | Novartis Ag | Oil-free pharmaceutical compositions containing cyclosporin A |
CZ301382B6 (cs) * | 1997-03-12 | 2010-02-10 | Abbott Laboratories Chad377/Ap6D-2 | Hydrofilní binární systémy pro podávání cyklosporinu |
US6008191A (en) * | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin |
US6346511B1 (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
US6187747B1 (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin |
AT408186B (de) * | 1998-12-15 | 2001-09-25 | Sanochemia Pharmazeutika Ag | Wässerige zubereitung von beta-carotin |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
DE10015814A1 (de) * | 2000-03-30 | 2001-10-11 | Max Planck Gesellschaft | Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung |
FR2826517B1 (fr) * | 2001-06-20 | 2004-03-12 | Somfy | Dispositif d'alimentation pour store motorise ou similaire |
MY145753A (en) * | 2001-10-19 | 2012-03-30 | Isotechnika Inc | Novel cyclosporin analog formulations |
US6979672B2 (en) | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions |
US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
US7288520B2 (en) * | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US20070015693A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US7276476B2 (en) * | 2005-07-13 | 2007-10-02 | Allergan, Inc. | Cyclosporin compositions |
US20070015691A1 (en) | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) * | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7501393B2 (en) * | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
US7745400B2 (en) * | 2005-10-14 | 2010-06-29 | Gregg Feinerman | Prevention and treatment of ocular side effects with a cyclosporin |
US9839667B2 (en) | 2005-10-14 | 2017-12-12 | Allergan, Inc. | Prevention and treatment of ocular side effects with a cyclosporin |
GB2451811A (en) | 2007-08-09 | 2009-02-18 | Ems Sa | Delivery composition for solubilising water-insoluble pharmaceutical active ingredients |
JP4815418B2 (ja) * | 2007-10-19 | 2011-11-16 | カヤバ工業株式会社 | 空圧緩衝器 |
WO2010029374A1 (en) * | 2008-09-12 | 2010-03-18 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
CA2852056C (en) | 2011-03-11 | 2021-08-10 | Beth Israel Deaconess Medical Center, Inc. | Anti-cd40 antibodies and uses thereof |
DK3307322T3 (da) | 2015-09-04 | 2021-04-19 | Primatope Therapeutics Inc | Humaniserede anti-cd40-antistoffer og anvendelser deraf |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3658M (fr) * | 1964-02-18 | 1965-11-02 | Michel Marie Andre Guerbet | Composition huileuse pour l'injection intravasculaire. |
DE2819094A1 (de) * | 1977-05-10 | 1978-11-23 | Sandoz Ag | Cyclosporin-derivate, ihre verwendung und herstellung |
DE2907460A1 (de) * | 1978-03-07 | 1979-09-13 | Sandoz Ag | Neue resorbierbare galenische kompositionen |
CH641356A5 (en) * | 1979-02-27 | 1984-02-29 | Sandoz Ag | Pharmaceutical compositions containing cyclosporin |
AU534955B2 (en) * | 1980-01-23 | 1984-02-23 | Sandoz Ag | Cyclosporin a to treat lymphoproliferative disorders |
DE3339235A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von polyurethanen |
DE3339236A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag | Arzneimittelzubereitung |
JPH02501389A (ja) * | 1987-10-02 | 1990-05-17 | フセソユズニ カルディオロジチェスキ ナウチニ ツェントル アカデミイ メディツィンスキフ ナウク エスエスエスエル | 多発性硬化症及び筋萎縮側索硬化症の治療用薬用製剤 |
GB8729153D0 (en) * | 1987-12-14 | 1988-01-27 | Efamol Ltd | Fatty acid compositions |
US4943560A (en) * | 1988-04-06 | 1990-07-24 | Regents Of The University Of Minnesota | Solvent system for chronic vascular infusion of hydrophobic drugs |
DE3832362A1 (de) * | 1988-09-23 | 1990-03-29 | Sandoz Ag | Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung |
-
1988
- 1988-07-21 HU HU883796A patent/HU201567B/hu unknown
-
1989
- 1989-07-20 FR FR8909767A patent/FR2635265B1/fr not_active Expired - Lifetime
- 1989-07-20 BE BE8900800A patent/BE1004323A4/fr not_active Expired - Lifetime
- 1989-07-21 CA CA000606313A patent/CA1332712C/en not_active Expired - Fee Related
- 1989-07-21 DE DE3924207A patent/DE3924207A1/de active Granted
- 1989-07-21 FI FI893520A patent/FI92556C/fi active IP Right Grant
- 1989-07-21 PT PT91246A patent/PT91246B/pt not_active IP Right Cessation
- 1989-07-21 LU LU87560A patent/LU87560A1/fr unknown
- 1989-07-21 CH CH2741/89A patent/CH679120A5/de not_active IP Right Cessation
- 1989-07-21 DD DD89331046A patent/DD283934A5/de not_active IP Right Cessation
- 1989-07-21 IL IL91069A patent/IL91069A/xx unknown
- 1989-07-21 GR GR890100467A patent/GR1002184B/el not_active IP Right Cessation
- 1989-07-21 GB GB8916679A patent/GB2221157B/en not_active Expired - Lifetime
- 1989-07-21 SE SE8902588A patent/SE509174C2/sv not_active IP Right Cessation
- 1989-07-21 US US07/383,024 patent/US5047396A/en not_active Expired - Lifetime
- 1989-07-21 NL NL8901902A patent/NL194578C/nl not_active IP Right Cessation
- 1989-07-21 KR KR1019890010365A patent/KR0137674B1/ko not_active IP Right Cessation
- 1989-07-21 AR AR89314460A patent/AR243382A1/es active
- 1989-07-21 DK DK198903621A patent/DK175540B1/da not_active IP Right Cessation
- 1989-07-21 AU AU38845/89A patent/AU614862B2/en not_active Expired
- 1989-07-21 IT IT8921259A patent/IT1231434B/it active
- 1989-07-21 AT AT0176789A patent/AT402258B/de not_active IP Right Cessation
- 1989-07-21 ZA ZA895588A patent/ZA895588B/xx unknown
- 1989-07-21 NZ NZ230036A patent/NZ230036A/xx unknown
- 1989-07-21 JP JP1190400A patent/JPH07116051B2/ja not_active Expired - Fee Related
- 1989-07-21 NO NO892995A patent/NO175287C/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI893520A0 (fi) | Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi | |
FI892640A0 (fi) | Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
FI98046B (fi) | Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
PT86819A (pt) | Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same | |
FI885884A (fi) | Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi | |
FI901787A0 (fi) | Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi | |
FI900604A0 (fi) | Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
FI890282A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
FI92934B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi | |
FI953056A (fi) | Menetelmä farmaseuttisten koostumusten valmistamiseksi ultraäänen avulla | |
HU896444D0 (en) | Process for the preparation of pharmaceutical compositions | |
FI891538A (fi) | Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi | |
FI98830B (fi) | Menetelmä bifunktionaalisten proteiinien valmistamiseksi | |
FI892058A0 (fi) | Fenolin valmistusmenetelmä | |
FI881303A (fi) | Menetelmä ibuprofeenin valmistamiseksi | |
FI104171B (fi) | Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi | |
FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
FI92065C (fi) | Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi | |
FI902316A0 (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä | |
FI102270B1 (fi) | Menetelmä dieettereiden valmistamiseksi | |
FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
PT87024A (pt) | Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same | |
FI93119B (fi) | Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä | |
FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
PT88681A (pt) | A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: BIOGAL GYOGYSZERGYAR RT. |
|
PC | Transfer of assignment of patent |
Owner name: TEVA GYOGYSZERGYAR ZARTKOERUEEN MUEKOEDOE RESZVENY Free format text: TEVA GYOGYSZERGYAR ZARTKOERUEEN MUEKOEDOE RESZVENYTARSASAG |